Den maksimale plasmakoncentration (Cmax) og plasma AUC for rufinamid stiger mindre end proportionalt med doserne hos både fastende og ikke fastende raske forsøgspersoner og hos patienter.
Peak concentration (Cmax) and plasma AUC of rufinamide increase less than proportionally with doses in both fasted and fed healthy subjects and in patients, probably due to dose-limited absorption behaviour.